Icoria, which was formerly known as Paradigm Genetics, has received another patent for its automated analysis and detection process.

Icoria said the patented technology is already being used by customers seeking to detect possible toxicity as part of drug discovery and development processes.

Icoria (Nasdaq: ICOR) now holds 27 patents.

Icoria: www.icoria.com